Literature DB >> 19218645

Prevalence of latent tuberculosis infection in health care workers in Poland assessed by interferon-gamma whole blood and tuberculin skin tests.

U Demkow1, B Broniarek-Samson, M Filewska, K Lewandowska, J Maciejewski, K Zycinska, Z Zwolska, J Kus.   

Abstract

Health care workers (HCWs) are at risk for developing active tuberculosis (TB). The prevalence of latent tuberculosis infection (LTBI) in this group is unknown in Poland, due largely to the problems associated with the interpretation of the tuberculin skin test (TST) in BCG immunized population. The goal of the present study was to assess the prevalence of LTBI in both clinical and non-clinical 155 HCWs (120 females and 35 males) and to compare the groups at different levels of risk. All participants were interviewed using a questionnaire and underwent interferon-gamma whole blood assay (Quantiferon-Tb-Gold) (QTF) and TST. The questionnaire provided information on possible risk factors for LTBI, including demographic and socioeconomic details, the presence of BCG scars, and the degree of occupational exposure. We found that the prevalence of LTBI among HCWs was, on average, 27.1%. A higher risk of acquiring LTBI was associated with certain work locations (TB lab workers--prevalence 50%, TB ward clinicians--34%, nurses--30%). The prevalence in analytical lab technicians was 20%, in administration staff was 15%. The HCWs with positive QTF test results were older and worked longer than those who had negative results. There was a significant correlation between the level of IFN-gamma and both age (P<0.001) and length of employment (P<0.01). The correlation between the diameter of skin test induration and the magnitude of the INF-gamma response also was significant (P<0.001). We conclude that HCWs are at increased risk of infection, suggesting that appropriate preventive strategies should be undertaken. IFN-gamma test is a useful tool in detecting LTBI cases in a country where BCG vaccination is a national policy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19218645

Source DB:  PubMed          Journal:  J Physiol Pharmacol        ISSN: 0867-5910            Impact factor:   3.011


  7 in total

1.  Utilization of the QuantiFERON-TB Gold test in a two-step process with the tuberculin skin test to evaluate health care workers for latent tuberculosis.

Authors:  Baha Abdalhamid; Steven H Hinrichs; Jodi L Garrett; Jean M O'Neill; Kristine M Hansen-Cain; Amy A Armbrust; Peter C Iwen
Journal:  J Clin Microbiol       Date:  2010-06-23       Impact factor: 5.948

2.  Latent tuberculosis in healthcare workers: time to act.

Authors:  Issa Al Jahdhami
Journal:  Oman Med J       Date:  2013-03

3.  Risk of latent TB infection in individuals employed in the healthcare sector in Germany: a multicentre prevalence study.

Authors:  Anja Schablon; Melanie Harling; Roland Diel; Albert Nienhaus
Journal:  BMC Infect Dis       Date:  2010-04-30       Impact factor: 3.090

Review 4.  European policies on tuberculosis prevention in healthcare workers: Which role for BCG? A systematic review.

Authors:  Marco Bo; Carla Maria Zotti
Journal:  Hum Vaccin Immunother       Date:  2016-07-07       Impact factor: 3.452

5.  Prevalence and Risk Factors for Latent Tuberculosis Infection among Health Care Workers in China: A Cross-Sectional Study.

Authors:  Xia Zhang; Hongyan Jia; Fei Liu; Liping Pan; Aiying Xing; Shuxiang Gu; Boping Du; Qi Sun; Rongrong Wei; Zongde Zhang
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

6.  Latent tuberculosis in nursing professionals of a Brazilian hospital.

Authors:  Karen Gisele Person Severo; Julia da Silva Oliveira; Marcelo Carneiro; Andréia Rosane de Moura Valim; Eliane Carlosso Krummenauer; Lia Gonçalves Possuelo
Journal:  J Occup Med Toxicol       Date:  2011-05-17       Impact factor: 2.646

7.  Identification of latent tuberculosis infection in rheumatic patients under consideration for treatment with anti-TNF-α agents.

Authors:  Jolanta Paluch-Oleś; Agnieszka Magryś; Maria Kozioł-Montewka; Arkadiusz Koszarny; Maria Majdan
Journal:  Arch Med Sci       Date:  2013-02-21       Impact factor: 3.318

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.